Diabetes Insipidus, Nephrogenic Panel

Nephrology

Diabetes Insipidus, Nephrogenic Panel

Overview

Test Name
Diabetes Insipidus, Nephrogenic Panel
Test Code
NEE1006
Test Category
Gene Panels
Test Subcategory
Nephrology
Disease(s) Targeted
Diabetes Insipidus, Nephrogenic
Who Is The Test For?
Patients with a family history, clinical suspicion, or diagnosis of diabetes insipidus, nephrogenic.
Test Approach

Whole exome sequencing (WES) with in silico gene panel analysis.

No. of Genes
3
Panel Content
AQP2, AVP, AVPR2
Deliverables
Turnaround Time

~3-6 weeks*

Specimen Requirements

For detailed information about the sample requirements, please consult our clinical sample requirements page.

*Turnaround times are estimated from receipt of satisfactory specimen and test request form at the laboratory to release of clinical report. The turnaround time may vary depending on the nature of the specimen and the complexity of the investigation required. The above table is only a guideline and the complexity of a case and the requirement for further investigations may change this.

About Diabetes Insipidus, Nephrogenic

Nephrogenic diabetes insipidus (NDI) is a rare kidney disorder where the kidneys are resistant to the antidiuretic hormone (ADH) or vasopressin, causing chronic excessive renal water loss leading to frequent urination (polyuria) and thirst (polydipsia). The most common form of inherited NDI is X-linked recessive, caused by variants in the AVPR2 gene which affects the arginine vasopressin receptor-2, which is involved in the maintenance of water homeostasis. Variants in the AQP2 gene, which encodes the aquaporin-2 water channel located in the renal collecting tubules, can cause autosomal NDI. The prevalence of NDI is low, with an estimated 8 cases per million male live births for the X-linked form.

Gene Panel Workflow

Order a test using our clinical portal

Preview Documents

©2023 Genseq All Rights Reserved.

Terms & Conditions
Privacy Policy
Cookie Policy
Cookie Preferences